Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.
Biotechnol Lett
; 39(9): 1309-1323, 2017 Sep.
Article
in En
| MEDLINE
| ID: mdl-28560579
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
G2 Phase
/
Receptor, ErbB-2
/
Cell Cycle Checkpoints
/
Antibodies
Limits:
Animals
/
Humans
Language:
En
Journal:
Biotechnol Lett
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: